ibrutinib
abbvie,janssen
['ibru', 'lymsm']
with respect to the br+ibrutinib study presented at #asco22, there were more treatment-related deaths in the ibrutinib arm. #lymsm 
Heme/onc fellow. #lymsm & #mmsm patient-reported outcomes researcher. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. ??????